Look Towards A New Future

Aug 13, 2012

Agricultural Biotechnology: Emerging Technologies and Global Markets

  • The global market for agricultural biotechnology was $13.7 billion in 2011 and is estimated to grow to $14.4 billion in 2012, growing at a compound annual growth rate (CAGR) of 11.4%, to reach a forecast value of nearly $24.8 billion in 2017.
  • Transgenic seeds make up the bulk of the agricultural biotechnology market, with a global value of $13.5 billion in 2011.  This market is expected to reach $14.1 billion in 2012 and is forecast to reach $20.4 billion by 2017, growing at a CAGR of 7.6%.
  • The synthetic biology-enabled products market was $192.7 million in 2011 and is expected to reach $199.8 million in 2012. This market is further projected to reach nearly $3.9 billion by 2017, a CAGR of 81.0% for a period of five years, i.e., 2012 to 2017.

BCC’s goal for this study is to determine the specific applications and forecast global market demand for agricultural biotechnology products over a five-year period from 2012 to 2017.  Our particular interest is to characterize and quantify the agricultural biotechnology products market potential by product type and end use market segments.  We also analyze the agricultural biotechnology industry structure, competitors and intellectual property landscape.
Agricultural biotechnology markets reviewed in this report include biotechnology tools, synthetic biology-enabled products and transgenic seeds.
Our key objective is to present a comprehensive analysis of the agricultural biotechnology industry, with an emphasis on products and technologies that are commercially important in the 2012 to 2017 time period.  Market segments with rapid growth rates are highlighted, as well as those segments with large market potential.  This analysis provides a quantitative basis and market context for companies to make strategic choices about participation in the agricultural biotechnology industry.
The study will be particularly useful to companies supplying agricultural seeds, synthetic genes, oligonucleotides, DNA sequencing instruments, cell culture media; biofuels, specialty chemicals, microfluidics and life sciences tools.


Agricultural biotechnology contains a wide range of products, and is of interest to a wide audience.  There are a significant number of near-term opportunities, as well as longer-term potential.  Applications include agriculture-themed microarrays and lab-on-chip devices, RNA interference assays, agriculture-derived biofuels and chemicals, and transgenic seeds.
This report examines these product applications and markets, helping companies to prioritize product opportunities and strategic opportunities.  Agricultural technologies are an important part of the global economy, and biotechnology is enabling science in this industry.  Therefore, it is important for both technology providers and traditional agricultural companies to understand the changes occurring in the industry.
Rapid changes in highly technical fields such as DNA sequencing and synthetic biology are driving new products in agriculture.  These developments create unique market opportunities.  This report analyzes these trends and their impact on future markets for agricultural products.
Based on these market and technology dynamics, it is especially timely to examine the current and future agricultural biotechnology markets.


We have compiled a study of existing and future agricultural biotechnology products and technologies that will be commercially important.
We present markets by product type (microarrays, DNA sequencing, biochips, synthetic biology-enabled and transgenic seeds), by crop type and by geography.  Important market segments covered include life science tools, synthetic biology and transgenic seeds.
We analyze agricultural biotechnologies, growth driving forces, market applications, industry structure and competitive dynamics; companies and industry alliances, future market potential, and product sales forecasts for the period 2012 through 2017.  We project the future value of agricultural biotechnology products by product type and geography.
This report will be of particular interest to agriculture, chemicals, enzymes, bioenergy and biotechnology companies, as well as suppliers of genomics tools, synthetic biology, RNA interference and DNA sequencing products.  It will also be of high interest to professionals within governments and regulatory agencies to understand the scope and pace of transgenic seeds as they continue to expand in the market.


The study scope includes emerging agricultural biotechnology tools (DNA sequencing, biochips and RNA interference), synthetic biology-enabled products and transgenic seeds that are already commercial or forecast to be commercialized within the next five years.
BCC analyzes key technologies and products to determine present and future market status and forecasted growth from 2012 through 2017.  We also discuss strategic alliances, industry structures, competitive dynamics, patent strategy and market driving forces.
BCC also examines the agricultural biotechnology industry structure, including the main transgenic seed companies, and the role of strategic alliances from 2010 through 2012.  The market for transgenic seeds by country and by crop type is presented.


BCC surveyed key users and producers in each of the end user market segments and technology fields that will be commercially important during the next five years.  Discussions with industry thought leaders, as well as secondary market research, were performed.
Based on our analysis, we analyze the future applications of agricultural biotechnologies in the major market segments and forecast global revenues for 2012 through 2017.


BCC surveyed leading life science tools, synthetic biology, biotechnology and agricultural seed companies to obtain data for this study.  Included were life science research tools, biotechnology, DNA sequencing, microfluidics firms and seed companies, as well as leading life science research institutions.  We also obtained inputs from leading academic and industry thought leaders.  Data from secondary sources included industry, trade and government publications.

The author, John Bergin, has written previous BCC biotechnology reports titled Epigenomics: Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics; Global Biochip Markets: Microarrays and Lab-on-a-chip; RNA Interference in the Post-Genomics Era:  Markets and Technologies; DNA Sequencing: Emerging Technologies and Applications; and Biologic Imaging Reagents: Technologies and Global Markets.  Mr. Bergin has held business development, sales and marketing positions with a Fortune 500 advanced materials company as well as executive management positions with an emerging nanotechnology company.  Mr. Bergin holds the following degrees:  B.S. Chemistry, M.S. Biotechnology and Masters of Business Administration.

Get your copy of this report @

Report Details:
Published: July 2012
No. of Pages: 130
Price: Single User License :US$4850            Corporate User License:US$8500